GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Synergy Pharmaceuticals Inc (FRA:S90) » Definitions » Shares Buyback Ratio %

Synergy Pharmaceuticals (FRA:S90) Shares Buyback Ratio % : -10.26 (As of May. 17, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Synergy Pharmaceuticals Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Synergy Pharmaceuticals's current shares buyback ratio was -10.26%.


Synergy Pharmaceuticals Shares Buyback Ratio % Historical Data

The historical data trend for Synergy Pharmaceuticals's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synergy Pharmaceuticals Shares Buyback Ratio % Chart

Synergy Pharmaceuticals Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
Shares Buyback Ratio %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -35.36 -7.13 -17.68 -78.33 -21.66

Synergy Pharmaceuticals Quarterly Data
Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18
Shares Buyback Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -9.65 - -0.49 -0.07

Synergy Pharmaceuticals Shares Buyback Ratio % Calculation

Synergy Pharmaceuticals's Shares Buyback Ratio for the fiscal year that ended in Dec. 2017 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Dec. 2016 ) - Shares Outstanding (EOP) (A: Dec. 2017 )) / Shares Outstanding (EOP) (A: Dec. 2016 )
=(202.74 - 246.66) / 202.74
=-21.66%

Synergy Pharmaceuticals's Shares Buyback Ratio for the quarter that ended in Sep. 2018 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Jun. 2018 ) - Shares Outstanding (EOP) (A: Sep. 2018 )) / Shares Outstanding (EOP) (A: Jun. 2018 )
=(247.86 - 248.04) / 247.86
=-0.07%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Synergy Pharmaceuticals Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of Synergy Pharmaceuticals's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Synergy Pharmaceuticals (FRA:S90) Business Description

Traded in Other Exchanges
N/A
Address
420 Lexington Avenue, Suite 2012, New York, NY, USA, 10170
Synergy Pharmaceuticals Inc functions in the healthcare sector based in the United States. It focusses on developing therapies to combat gastrointestinal diseases. The company's basic ingredient is the uroguanylin analog, which it employs in its products candidates such as plecanatide and dolcanatide. Plecanatide is a once-daily tablet, which addresses chronic idiopathic constipation and the irritable bowel syndrome. Dolcanatide is meant to cure inflammatory bowel disease by aiding the process of digestive breakdown.

Synergy Pharmaceuticals (FRA:S90) Headlines

No Headlines